Enochian Biosciences, Inc.

Enochian Biosciences, Inc.verified

ENOB

Price:

$0.7125

Market Cap:

$32.92M

Enochian Biosciences, Inc. is a pre-clinical biotechnology firm dedicated to the research and advancement of novel pharmaceutical and biological agents. Its primary focus lies in developing treatments for a range of human diseases, including human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza, coronavirus infections, and various cancers. The company's leading investigational products encompass ENOB-HV-01, an autologous therapy aimed at achieving an HIV cure; ENOB-HV-11, a preventative HIV vaccine candidate; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, which targets the HBV polymerase. Beyond these primary programs, Enochian Biosciences' developmental pipeline als...[Read more]

Industry

Biotechnology

IPO Date

2018-02-07

Stock Exchange

NASDAQ

Ticker

ENOB

The ROE as of June 2026 (TTM) for Enochian Biosciences, Inc. (ENOB) is 892.52%

According to Enochian Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 892.52%. This represents a change of 483.18% compared to the average of 153.04% of the last 4 quarters.

Enochian Biosciences, Inc. (ENOB) Historical ROE (quarterly & annually)

How has ENOB ROE performed in the past?

The mean historical ROE of Enochian Biosciences, Inc. over the last ten years is 62.70%. The current 892.52% ROE has changed 1.32% with respect to the historical average. Over the past ten years (40 quarters), ENOB's ROE was at its highest in in the June 2025 quarter at 593.60%. The ROE was at its lowest in in the June 2022 quarter at -124.26%.

Quarterly (TTM)
Annual

Average

62.70%

Median

-12.85%

Minimum

-156.20%

Maximum

833.76%

Enochian Biosciences, Inc. (ENOB) ROE by Quarter and Year

Discovering the peaks and valleys of Enochian Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 920.93%

Maximum Annual ROE = 833.76%

Minimum Annual Increase = -1464.39%

Minimum Annual ROE = -156.20%

Quarterly (TTM)
Annual
YearROEChange
2025833.76%-1464.39%
2024-61.11%-28.39%
2023-85.34%-45.37%
2022-156.20%920.93%
2021-15.30%122.84%
2020-6.87%-34.03%
2019-10.41%161.76%
2018-3.98%-97.16%
2017-139.80%-151.35%
2016272.24%-499.85%

Enochian Biosciences, Inc. (ENOB) Average ROE

How has ENOB ROE performed in the past?

The current ROE of Enochian Biosciences, Inc. (ENOB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

229.11%

5-year avg

103.16%

10-year avg

62.70%

Enochian Biosciences, Inc. (ENOB) ROE vs. Peers

How is ENOB’s ROE compared to its peers?

Enochian Biosciences, Inc.’s ROE is greater than GreenLight Biosciences Holdings (-1847.24%), greater than Rein Therapeutics Inc. (-258.45%), less than bluebird bio, Inc. (129.26%), greater than Spyre Therapeutics, Inc. (-31.25%), greater than Magenta Therapeutics, Inc. (-27.30%), greater than AlloVir, Inc. (-72.78%), less than Pluristem Therapeutics Inc. (79.27%), greater than Eyenovia, Inc. (-63.54%), greater than ERYTECH Pharma S.A. (-95.68%), less than LianBio (11.78%),

Build a custom stock screener for Enochian Biosciences, Inc. (ENOB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enochian Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enochian Biosciences, Inc. (ENOB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enochian Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Enochian Biosciences, Inc.'s ROE?

How is the ROE calculated for Enochian Biosciences, Inc. (ENOB)?

What is the highest ROE for Enochian Biosciences, Inc. (ENOB)?

What is the 3-year average ROE for Enochian Biosciences, Inc. (ENOB)?

What is the 5-year average ROE for Enochian Biosciences, Inc. (ENOB)?

How does the current ROE for Enochian Biosciences, Inc. (ENOB) compare to its historical average?